Celsion Transitioning From Development To Commercial-Stage Company; Relocates To N.J.
This article was originally published in The Pink Sheet Daily
Executive Summary
Biotech's primary liver cancer drug ThermoDox should produce pivotal Phase III data in the next 12 to 14 months.